Work With Data
Profile
user
live In the news:
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs / Stocks making the biggest moves after hours: Tesla, Enphase Energy, Oklo, Bristol Myers Squibb and more / Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance / Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug / Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint / Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson / Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma / Bristol Myers Squibb results top estimates as new drugs post strong sales growth / Bristol Myers Squibb to Discontinue Metastatic Colorectal Cancer Trial

Bristol Myers Squibb

Updated: 2d ago
bookmarkBookmark

Bristol Myers Squibb is a company. It is a public company in New York, the United States. It was founded in 1887 and its current CEO is Giovanni Caforio. It is part of the Health Care sector, specifically in the Pharmaceuticals industry.

Key facts

plus See more facts

Extract data

Download datasets about Bristol Myers Squibb:

dataset Dataset of stocks from Bristol Myers Squibb:

Bristol Myers Squibb is one of the companies in the United States, companies in Pharmaceuticals, companies in Health Care, companies in New York and 3,456,835 companies in our database.

Talking Points

  • Global Biopharmaceutical CompanyBristol Myers Squibb
  • Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
  • We discover, develop and deliver innovative medicines that help patients prevail over serious diseases. | Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our medicines are helping millions of patients around the world in ...
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
  • スペシャリティ・バイオファーマ「ブリストル マイヤーズ スクイブ」
  • ブリストル マイヤーズ
  • At Bristol Myers Squibb, we work every day to transform patients' lives through science. That work inspires some of the most interesting,...
  • Bristol Myers Squibb - Global Biopharmaceutical Company
  • Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
  • Swords Laboratories is a pharmaceuticals company based out of Watery Lane, Swords, Dublin, Ireland.
  • Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
  • Your Meaningful Career at Bristol Myers Squibb
  • Discover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.
  • Patients are our purpose. We come together each day to discover, develop and deliver transformative science to help patients prevail over serious diseases.
  • Our Company: Industry Leadership in BioPharma - Bristol Myers Squibb
  • Learn more about Bristol Myers Squibb, a global biopharma company dedicated to discover, develop and deliver innovative medicines to patients with serious diseases.
  • Similar pages Zymo Research Corp Biotechnology Research Irvine, California ... ZymoGenetics ZymoGenetics Skip to ...
  • Researchers - Bristol Myers Squibb
  • Our research pipeline is the result of passionate discovery efforts & innovative partnerships. Read more about our research!

Related

Connected or similar to Bristol Myers Squibb: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.